U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TALIMOGENE LAHERPAREPVEC
07730V90L6
Possibly Marketed Outside US
First approved in 2015
General
Record Details
Names
11
Classification
6
Identifiers
12
Subunits
1
Sugars
1
Linkages
1
Active Moiety
1
TALIMOGENE LAHERPAREPVEC
07730V90L6
Possibly Marketed Outside US
First approved in 2015
General
Approval Year
2015
471
Record Details
Substance Class
Nucleic Acid
Nucleic Acid Subtype
Sequence Type
P0LYNUCLEOTIDE
Record UNII
07730V90L6
Record Status
Validated (UNII)
Record Version
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TALIMOGENE LAHERPAREPVEC
Official Name
English
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Common Name
English
TALIMOGENE LAHERPAREPVEC [USAN]
Common Name
English
IMLYGIC
Brand Name
English
ONCOVEXGM-CSF
Common Name
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
6
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Immunotherapeutic Agent
Pharmacologic Substance
[C1909]
Immunotherapeutic Agent
[C308]
Immunostimulant
NCI_THESAURUS
C2139
Other antineoplastic agents
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Other antineoplastic agents
talimogene laherparepvec
WHO-ATC
L01XX51
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Oncolytic Virus
NCI_THESAURUS
C717
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of stage IIb-stage IV melanoma
FDA ORPHAN DRUG
334011
NEVI AND MELANOMAS
EMA EPAR
DISEASES
CANCER
NEOPLASMSBY HOLISTIC TYPE
NEVI AND MELANOMAS
MELANOMA
EMA ASSESSMENT REPORTS
IMLYGIC (AUTHORIZED: MELANOMA)
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
12
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
WIKIPEDIA
Talimogene laherparepvec
PRIMARY
DRUG CENTRAL
5180
PRIMARY
RXCUI
1721264
PRIMARY
RxNorm
NCI_THESAURUS
C61314
PRIMARY
FDA UNII
07730V90L6
PRIMARY
Showing 1 to 5 of 12 entries
Previous
1
2
3
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Sugars
1
Show
5
20
100
All
entries
Sugar
Site Range
Site Count
Sugar
Site Range
Site Count
Deoxyribose (DNA)
1_1-1_7556
7556 / 7556
Showing 1 to 1 of 1 entries
Previous
1
Next
Linkages
1
Show
5
20
100
All
entries
Linkage
Site Range
Site Count
Linkage
Site Range
Site Count
Phosphate
1_1-1_7556
7556 / 7555
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
07730V90L6
TALIMOGENE LAHERPAREPVEC
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
